DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Goldman Sachs Downgrades Viela Bio to Neutral

Goldman Sachs analyst Paul Choi downgrades Viela Bio (NASDAQ:VIE) from Buy to Neutral.

Benzinga · 02/04/2020 10:31

Goldman Sachs analyst Paul Choi downgrades Viela Bio (NASDAQ:VIE) from Buy to Neutral.